American Heart Association Launches Lipid Management Initiative
The majority of people at risk for cardiovascular disease do not achieve recommended cholesterol levels despite the availability of effective therapies and evidence-based treatment guidance. Clinical workflow complexities, treatment escalation challenges, referral processes, prior authorization requirements and patient engagement barriers can all affect access to timely, guideline-directed care.